Disruption of fungal cell wall by antifungal Echinacea extracts.

In addition to widespread use in reducing the symptoms of colds and flu, Echinacea is traditionally employed to treat fungal and bacterial infections. However, to date the mechanism of antimicrobial activity of Echinacea extracts remains unclear. We utilized a set of ∼4,600 viable gene deletion mutants of Saccharomyces cerevisiae to identify mutations that increase sensitivity to Echinacea. Thus, a set of chemical-genetic profiles for 16 different Echinacea treatments was generated, from which a consensus set of 23 Echinacea-sensitive mutants was identified. Of the 23 mutants, only 16 have a reported function. Ten of these 16 are involved in cell wall integrity/structure suggesting that a target for Echinacea is the fungal cell wall. Follow-up analyses revealed an increase in sonication-associated cell death in the yeasts S. cerevisiae and Cryptococcus neoformans after Echinacea extract treatments. Furthermore, fluorescence microscopy showed that Echinacea-treated S. cerevisiae was significantly more prone to cell wall damage than non-treated cells. This study further demonstrates the potential of gene deletion arrays to understand natural product antifungal mode of action and provides compelling evidence that the fungal cell wall is a target of Echinacea extracts and may thus explain the utility of this phytomedicine in treating mycoses.

Antifungal and antioxidant activities of the phytomedicine pipsissewa, Chimaphila umbellata.

Bioassay-guided fractionation of Chimaphila umbellata (L.) W. Bart (Pyrolaceae) ethanol extracts led to the identification of 2,7-dimethyl-1,4-naphthoquinone (chimaphilin) as the principal antifungal component. The structure of chimaphilin was confirmed by 1H and 13C NMR spectroscopy. The antifungal activity of chimaphilin was evaluated using the microdilution method with Saccharomyces cerevisiae (0.05mg/mL) and the dandruff-associated fungi Malassezia globosa (0.39mg/mL) and Malassezia restricta (0.55mg/mL). Pronounced antioxidant activity of C. umbellata crude extract was also identified using the DPPH (2,2-diphenyl-1-picrylhydrazyl) assay, suggesting this phytomedicine has an antioxidant function in wound healing. A chemical-genetic profile was completed with chimaphilin using approximately 4700 S. cerevisiae gene deletion mutants. Cellular roles of deleted genes in the most susceptible mutants and secondary assays indicate that the targets for chimaphilin include pathways involved in cell wall biogenesis and transcription.

Acylated anthocyanins in inflorescence of spider flower (Cleome hassleriana).

Five anthocyanins, cyanidin 3-(2''-(6'''-caffeoyl-beta-glucopyranosyl)-6''-(E-p-coumaroyl)-beta-glucopyranoside)-5-beta-glucopyranoside, cyanidin 3-(2''-(6'''-E-sinapoyl-beta-glucopyranosyl)-6''-(E-p-coumaroyl)-beta-glucopyranoside)-5-beta-glucopyranoside, cyanidin 3-(2''-(6'''-feroyl-beta-glucopyranosyl)-6''-(E-p-coumaroyl)-beta-glucopyranoside)-5-beta-glucopyranoside, pelargonidin 3-(2''-(6'''-E-sinapoyl-beta-glucopyranosyl)-6''-(E-p-coumaroyl)-beta-glucopyranoside)-5-beta-glucopyranoside, and pelargonidin 3-(2''-(6'''-E-p-coumaroyl-beta-glucopyranosyl)-6''-(E-p-coumaroyl)-beta-glucopyranoside)-5-beta-glucopyranoside, together with five known anthocyanins have been identified in flowers of Cleome hassleriana Queen line. One monoacylated and four diacylated cyanidin 3-sophoroside-5-glucosides were identified as the main anthocyanins in flowers with mauve colouration, while a homologous glycosidic pattern based on pelargonidin was found in the five main anthocyanins from flowers with pink colouration. The anthocyanins identified in C. hassleriana share the same glycosidic pattern as anthocyanins isolated from the genera Raphanus, Brassica and Iberis in the sister family Brassicaceae.